Angiotensin-Converting

Angiotensin-converting enzyme 2 is the rate-limiting enzyme of Ang ( 1-7 ).

血管紧张素转换酶2是Ang ( 1-7 ) 的限速酶.

Objective To evaluate the pharmaceutical effect of angiotensin-converting enzyme inhibitor ( ACEI ) captopril on ischemic myocardium.

目的评价血管紧张素转换酶抑制剂 ( ACEI ) 卡托普利对缺血心肌的药理作用.

Objective To study the correlation between the angiotensin converting enzyme ( ACE ) gene polymorphism and cerebral hemorrhage.

目的探讨血管紧张素转换酶 ( ACE ) 基因多态性和脑出血发病的关系.

Background-Angiotensin-converting enzyme inhibitor therapy improves clinical outcome and ventricular function in adults with heart failure.

血管紧张素转换酶抑制剂治疗成年人心衰能够改善患者的临床表现和心室功能.

ACE ( angiotensin-converting enzyme ) inhibitors help to lower blood pressure and reduce strain on your heart.

血管紧缩素转换 酶 抑制剂.有助于降低血压并降低心脏的负担.

Angiotensin-converting enzyme inhibitors might prevent arterial stenosis and atherosclerosis development after stent implantation.

血管紧张素转换酶抑制剂对支架置入后血管内膜的增殖具有抑制作用.

Objective: To invesgate the correlation between Angiotensin converting enzyme ( ACE ) gene polymorphism and Henoch-Schonlein purpura nephritis ( HSPN ) in children.

目的: 探讨血管紧张素转换酶 ( ACE ) 基因多态性与儿童紫癜性肾炎 ( HSPN ) 的关系.

Isolation and Purification of Angiotensin Converting Enzyme InhibitoryPeptides by High Performance Liquid Chromatography.

高效液相色谱分离纯化血管紧张素转换酶活性抑制肽.

AIM: Cilazapril is the third generation of angiotensin converting enzyme inhibitor.

西拉普利属第3代血管紧张肽转换酶抑制药.

Angiotensin converting enzyme gene ACE is considered to be related to cardiovascular endurance performance.

血管张力素转化酶基因被认为与心血管耐力表现有关.

Definitive determination of the benefit of angiotensin-converting angiotensin-receptor blockade.

而血管紧张素转化酶抑制剂疗法获益的确切结果则需要像血管紧张素受体拮抗剂一样的确定性临床试验研究.